Remember That DNA You Gave 23andMe? - The Atlantic
theatlantic.com · 1,241 words · saved by 1 readers
The company is in trouble, and anyone who has spit into one of the company’s test tubes should be concerned.
Listen − 1.0 x + Seek 0:00 7:56 23andMe is not doing well . Its stock is on the verge of being delisted. It shut down its in-house drug-development unit last month, only the latest in several rounds of layoffs. Last week, the entire board of directors quit, save for Anne Wojcicki, a co-founder and the company’s CEO. Amid this downward spiral, Wojcicki has said she’ll consider selling 23andMe—which means the DNA of 23andMe’s 15 million customers would be up for sale, too. 23andMe’s trove of genetic data might be its most valuable asset. For about two decades now, since human-genome analysis bec
related reading
- The 23andMe Deal - Cremieux Recueilcremieux.xyz
- How to Secure the DNA Supply Chain | IFPifp.org
- Your DNA Test for a Healthier Lifestyle.3x4genetics.com
- How I sequenced my genome at home - home-seqiwantosequencemygenomeathome.com
- Gene Genies: Inside The Revolutionary Biotech That Can Edit DNA Inside Living Humansforbes.com
- Personal genomicsen.wikipedia.org
- Nature's drug database - The Works in Progress Newsletterworksinprogress.news
- Dyno Therapeutics: The Capsids You Needcenturyofbio.com
- DNA Nutrigenomic Test with Methylation Pathway Analysisholisticheal.com
- What's different? Part one: Sequencingcenturyofbio.com
- AlphaGenome: AI for better understanding the genome — Google DeepMinddeepmind.google
- A24, Google DeepMind and the Dangerous Business of Selling Cooltheankler.com